Cargando…

Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling

Prevailing insulin resistance and the resultant hyperglycemia elicits a compensatory response from pancreatic islet beta cells (β-cells) that involves increases in β-cell function and β-cell mass. However, the sustained metabolic stress eventually leads to β-cell failure characterized by severe β-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji-Hyeon, Mellado-Gil, Jose Manuel, Bahn, Young Jae, Pathy, Sushrut M., Zhang, Ying E., Rane, Sushil G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070087/
https://www.ncbi.nlm.nih.gov/pubmed/32170115
http://dx.doi.org/10.1038/s41419-020-2365-8
_version_ 1783505905520738304
author Lee, Ji-Hyeon
Mellado-Gil, Jose Manuel
Bahn, Young Jae
Pathy, Sushrut M.
Zhang, Ying E.
Rane, Sushil G.
author_facet Lee, Ji-Hyeon
Mellado-Gil, Jose Manuel
Bahn, Young Jae
Pathy, Sushrut M.
Zhang, Ying E.
Rane, Sushil G.
author_sort Lee, Ji-Hyeon
collection PubMed
description Prevailing insulin resistance and the resultant hyperglycemia elicits a compensatory response from pancreatic islet beta cells (β-cells) that involves increases in β-cell function and β-cell mass. However, the sustained metabolic stress eventually leads to β-cell failure characterized by severe β-cell dysfunction and progressive loss of β-cell mass. Whereas, β-cell dysfunction is relatively well understood at the mechanistic level, the avenues leading to loss of β-cell mass are less clear with reduced proliferation, dedifferentiation, and apoptosis all potential mechanisms. Butler and colleagues documented increased β-cell apoptosis in pancreas from lean and obese human Type 2 diabetes (T2D) subjects, with no changes in rates of β-cell replication or neogenesis, strongly suggesting a role for apoptosis in β-cell failure. Here, we describe a permissive role for TGF-β/Smad3 in β-cell apoptosis. Human islets undergoing β-cell apoptosis release increased levels of TGF-β1 ligand and phosphorylation levels of TGF-β’s chief transcription factor, Smad3, are increased in human T2D islets suggestive of an autocrine role for TGF-β/Smad3 signaling in β-cell apoptosis. Smad3 phosphorylation is similarly increased in diabetic mouse islets undergoing β-cell apoptosis. In mice, β-cell-specific activation of Smad3 promotes apoptosis and loss of β-cell mass in association with β-cell dysfunction, glucose intolerance, and diabetes. In contrast, inactive Smad3 protects from apoptosis and preserves β-cell mass while improving β-cell function and glucose tolerance. At the molecular level, Smad3 associates with Foxo1 to propagate TGF-β-dependent β-cell apoptosis. Indeed, genetic or pharmacologic inhibition of TGF-β/Smad3 signals or knocking down Foxo1 protects from β-cell apoptosis. These findings reveal the importance of TGF-β/Smad3 in promoting β-cell apoptosis and demonstrate the therapeutic potential of TGF-β/Smad3 antagonism to restore β-cell mass lost in diabetes.
format Online
Article
Text
id pubmed-7070087
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70700872020-03-18 Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling Lee, Ji-Hyeon Mellado-Gil, Jose Manuel Bahn, Young Jae Pathy, Sushrut M. Zhang, Ying E. Rane, Sushil G. Cell Death Dis Article Prevailing insulin resistance and the resultant hyperglycemia elicits a compensatory response from pancreatic islet beta cells (β-cells) that involves increases in β-cell function and β-cell mass. However, the sustained metabolic stress eventually leads to β-cell failure characterized by severe β-cell dysfunction and progressive loss of β-cell mass. Whereas, β-cell dysfunction is relatively well understood at the mechanistic level, the avenues leading to loss of β-cell mass are less clear with reduced proliferation, dedifferentiation, and apoptosis all potential mechanisms. Butler and colleagues documented increased β-cell apoptosis in pancreas from lean and obese human Type 2 diabetes (T2D) subjects, with no changes in rates of β-cell replication or neogenesis, strongly suggesting a role for apoptosis in β-cell failure. Here, we describe a permissive role for TGF-β/Smad3 in β-cell apoptosis. Human islets undergoing β-cell apoptosis release increased levels of TGF-β1 ligand and phosphorylation levels of TGF-β’s chief transcription factor, Smad3, are increased in human T2D islets suggestive of an autocrine role for TGF-β/Smad3 signaling in β-cell apoptosis. Smad3 phosphorylation is similarly increased in diabetic mouse islets undergoing β-cell apoptosis. In mice, β-cell-specific activation of Smad3 promotes apoptosis and loss of β-cell mass in association with β-cell dysfunction, glucose intolerance, and diabetes. In contrast, inactive Smad3 protects from apoptosis and preserves β-cell mass while improving β-cell function and glucose tolerance. At the molecular level, Smad3 associates with Foxo1 to propagate TGF-β-dependent β-cell apoptosis. Indeed, genetic or pharmacologic inhibition of TGF-β/Smad3 signals or knocking down Foxo1 protects from β-cell apoptosis. These findings reveal the importance of TGF-β/Smad3 in promoting β-cell apoptosis and demonstrate the therapeutic potential of TGF-β/Smad3 antagonism to restore β-cell mass lost in diabetes. Nature Publishing Group UK 2020-03-13 /pmc/articles/PMC7070087/ /pubmed/32170115 http://dx.doi.org/10.1038/s41419-020-2365-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lee, Ji-Hyeon
Mellado-Gil, Jose Manuel
Bahn, Young Jae
Pathy, Sushrut M.
Zhang, Ying E.
Rane, Sushil G.
Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
title Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
title_full Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
title_fullStr Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
title_full_unstemmed Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
title_short Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
title_sort protection from β-cell apoptosis by inhibition of tgf-β/smad3 signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070087/
https://www.ncbi.nlm.nih.gov/pubmed/32170115
http://dx.doi.org/10.1038/s41419-020-2365-8
work_keys_str_mv AT leejihyeon protectionfrombcellapoptosisbyinhibitionoftgfbsmad3signaling
AT melladogiljosemanuel protectionfrombcellapoptosisbyinhibitionoftgfbsmad3signaling
AT bahnyoungjae protectionfrombcellapoptosisbyinhibitionoftgfbsmad3signaling
AT pathysushrutm protectionfrombcellapoptosisbyinhibitionoftgfbsmad3signaling
AT zhangyinge protectionfrombcellapoptosisbyinhibitionoftgfbsmad3signaling
AT ranesushilg protectionfrombcellapoptosisbyinhibitionoftgfbsmad3signaling